cromolyn sodium has been researched along with amyloid beta-peptides in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Elmaleh, DR; Forte, AM; Griciuc, A; Hudry, E; Quinti, L; Ran, C; Shen, X; Tanzi, RE; Wan, Y; Ward, J; Zhang, C | 1 |
1 other study(ies) available for cromolyn sodium and amyloid beta-peptides
Article | Year |
---|---|
Cromolyn Reduces Levels of the Alzheimer's Disease-Associated Amyloid β-Protein by Promoting Microglial Phagocytosis.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Anti-Asthmatic Agents; Brain; Cromolyn Sodium; Disease Models, Animal; Drug Combinations; Drug Repositioning; Gene Expression; Humans; Ibuprofen; Male; Mice; Mice, Transgenic; Microglia; Neurons; Neuroprotective Agents; Peptide Fragments; Phagocytosis; Transgenes | 2018 |